FDA -- Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

Data concepts (not just the information but the underlying definition of its meaning) between many different sources of real-world data (RWD) (e.g., EHRs, Claims, and digital health technologies) as well as those used in clinical research and regulatory submissions are almost always similar but not identical.  This difference requires  mapping and transforming data between RWD and clinical research use to rely heavily on human interpretation and is an obstacle to developing a fully reliable computer-driven approach.  This request for applications is aimed at defining the elemental components of RWD in a way that may support future computable approaches to defining what is currently only implied by definitions of data elements or business practices to facilitate standardization for regulatory submissions.


  • Letter of Intent Due Date(s): February 7, 2022

  • Application Due Date(s): March 31, 2022

RFA-FD-22-022 Expiration Date April 1, 2022

Agency Website

Amount Description

Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):

YR 01: $250,000

YR 02: $100,000

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

March 31, 2022